| Document |
Document Title |
|
WO/2023/168827A1 |
The present invention relates to the technical field of chemical intermediates. Disclosed is a synthesis method for a paxlovid intermediate, comprising the following steps: reacting 3,3-dimethyl-4-oxobutyrate with S-substituted sulfinami...
|
|
WO/2023/146973A1 |
The present invention relates to improved preparation of a KIF18A inhibitor having the chemical structure Compound (1), or a salt thereof Compound (1a); wherein HA is as defined herein; and key intermediates thereof, i.e., Compound (2a),...
|
|
WO/2023/015184A1 |
Provided herein is a process for the preparation of (R)-N-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden
-1-yl)-1-methyl-1H-pyrazole-4-carboxamide, intermediates thereof, and salts of the foregoing.
|
|
WO/2022/232949A1 |
The present application includes a process for preparing the (R)- or (S)- enantiomers of 3,4-methylenedioxymethamphetamine ((R)-MDMA or (S)-MDMA) and (R)- or (S)-N-methyl-1,3-benzodioxolylbutanamine ((R)-MBDB or (S)-MBDB) using (R)- tert...
|
|
WO/2022/220231A1 |
The purpose of the present invention is to provide a novel technique which can be employed in the production of a fluorinated substance using 2,6-dimethyl-4-t-butyl-trifluorosulfanylbenzene, whereby it becomes possible to remove an SOF t...
|
|
WO/2022/203074A1 |
Provided is a non-aqueous electrolyte containing a non-aqueous electrosolvent and a lithium salt, wherein the non-aqueous solvent includes a carbonate solvent, the lithium salt contains a fluorine-containing cyclic sulfonylimide salt rep...
|
|
WO/2022/195221A1 |
The present invention relates to a crosslinkable two-component composition comprising: - a component A comprising: - a compound having the following formula (I): - at least one (meth)acrylate monomer M1 having one of formulae (II), (III)...
|
|
WO/2022/125620A1 |
There is currently a high demand for new therapeutic antibiotics with new mechanisms of action. Disclosed are two small molecules, tryglysin A and B, with novel chemical structures and potent antibiotic activity against a narrow spectrum...
|
|
WO/2022/114138A1 |
Provided is a novel method for producing a (1R,2R,3R,5R,6R)-2-amino-6-fluoro-3-[(4-fluorophenyl)methoxy
]bicycle[3.1.0]hexane-2,6-dicarboxylic acid. This production method is characterized by relying on the conversion from a compound rep...
|
|
WO/2021/172112A1 |
The present invention provides: an actinic ray-sensitive or radiation-sensitive resin composition, represented by specific general formula (1), containing (A) a resin, and (B) a compound that produces an acid when irradiated with actinic...
|
|
WO/2021/161218A1 |
The present invention relates to compounds that can act as modulators of the nuclear receptor peroxisome proliferator-activated receptor α, y and/or δ (PPARα, PPARy and/or PPARδ) and that can be useful in the treatment of diseases an...
|
|
WO/2021/123237A1 |
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(amino-oxo-aryl-λ6- sulfanylidene)acetamide compounds (referred to herein as ANASIA co...
|
|
WO/2021/028810A1 |
The present invention relates to certain compounds, their use in therapy, as well as to pharmaceutical compositions including said compounds. Specifically, the invention relates to certain compounds and pharmaceutical compositions includ...
|
|
WO/2020/188387A1 |
The present disclosure relates to a process for the preparation of trifluoromethanesulfinyl chloride. Trifluoromethanesulfinyl chloride is used as an intermediate for preparing pesticides and insecticides. Trifluoromethanesulfinyl chlori...
|
|
WO/2020/077024A1 |
Compounds and pharmaceutically acceptable salts thereof of Formula I are disclosed. The variables, e.g. R1-R9, X, and Y are defined herein. Certain compounds and salts of Formula I are active as CMA modulators. The disclosure provides ph...
|
|
WO/2020/056653A1 |
The present invention discloses a method for preparing a perfluoroalkyl sulfinate ester, comprising: subjecting an α-carbonyldiazo compound and sodium perfluoroalkyl sulfinate, which serve as reaction substrates, to a coupling reaction ...
|
|
WO/2020/012403A1 |
The present invention relates to an improved process for diastereoselective synthesis of vicinal diamines (1). The process involves highly regio- and diastereoselective addition of 2-azaallyl anions (4) to N-tert-butanesulfinylimines (5)...
|
|
WO/2019/115597A1 |
Enantiopure terphenyl presenting two ortho-located chiral axes having the following structural formula (I) : their process of synthesis and their use as mono or bidentate ligands for asymmetric organometallic reactions, as organocatalyst...
|
|
WO/2018/229083A1 |
The present invention relates to compounds, in particular those of formula (I) and formula (II) described herein, or pharmaceutically acceptable salts or solvates thereof, which may be used as radioligands in in vitro, ex vivo and in viv...
|
|
WO/2018/206728A1 |
The invention relates to the use of a precursor for the production of carbon-11-labelled amino acids or derivatives thereof. According to the invention, the precursor is a compound of formula I: (formula I), where R1 and R2 are selected ...
|
|
WO/2018/186331A1 |
The purpose of the present invention is to provide a modification method for a mixture containing a trifluorosulfanyl aromatic compound and a fluorosulfinyl aromatic compound, wherein one or both of these compounds are converted into der...
|
|
WO/2018/162399A1 |
The invention relates to a synergistically active composition which comprises a mixture of a sulfinic acid or a salt thereof and ascorbic acid or a salt thereof and the use of the composition as reducing agent. The reducing power of the ...
|
|
WO/2018/108925A1 |
A sulfonic acid salt composition comprises compounds of formula (I), wherein n is 1 or 2,R1 is H or C1-C6 alkyl, R2 is COOM, SO3M or CH(OH)SO2-OM, each M is an equivalent of a multivalent metal, preferably magnesium, calcium, aluminum, z...
|
|
WO/2018/108922A1 |
The invention relates to mixed salts of hydroxyalkane sulfinic acids and optionally hydroxyalkane sulfonic acids, their preparation and the use of said salts as reducing agent. The reducing power of the salts of the invention is signific...
|
|
WO/2017/099662A1 |
A method for producing derivatives of N-retinoylaminoalkane sulfonic acid, the method comprising providing retinoic acid, chloroformate, aminoalkanesulfonic acid selected from the group consisting of cysteic acidand alkyl ester thereof, ...
|
|
WO/2017/051326A1 |
The invention relates to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, in particular neutral endopeptidase (NEP) inhibitors such as sacubitril, and prodrugs the...
|
|
WO/2016/143634A1 |
Provided is a bimesogenic compound which exhibits high solubility in other bimesogenic compounds and substances used in conventional liquid crystal display elements, such as liquid crystalline compounds, liquid crystal compositions, chir...
|
|
WO/2016/142315A1 |
The invention relates to a process for preparing an oxysulphide and fluorinated compound, which comprises reacting, in the presence of an organic solvent, at least one compound of formula Ea-X (I), in which Ea is a fluorine atom or a gro...
|
|
WO/2016/091772A1 |
The invention relates to a method for producing an oxysulphidic and fluorinated derivative in the form of a salt of formula (II) Ea-SOO-Q+ (II) comprising providing an ionic liquid compound of formula (I) in the liquid state Ea-SOO-Q+ (I...
|
|
WO/2015/087352A1 |
The present patent discloses a novel, efficient and transition-metal-free room temperature single step process for synthesis of aryl sulfones and substituted aryl sulfones starting from aryl substrates.
|
|
WO/2015/060402A1 |
Provided are a novel production method for trifluoromethanesulfonanilides, which are useful as herbicides, etc., and intermediates therefor. Specifically provided are: an industrially-useful production method for producing a trifluorom...
|
|
WO/2015/036504A1 |
The invention concerns a method for preparing an oxysulphide and fluorinated derivative, said method comprising the reacting, in the presence of an organic solvent, of: i) at least one compound of formula Ea-COOR (I), in which Ea represe...
|
|
WO/2014/186571A1 |
Bezoxazole sulfenamide accelerators are provided. The bezoxazole sulfenamide accelerators may be used in cure system for the vulcanization of rubber. The bezoxazole sulfenamide accelerators may also be used in asphalt and polymer composi...
|
|
WO/2014/081558A1 |
Disclosed is a process for making diastereomeric N-sulfinyl α-amino amides by reaction of chiral sulfinimines with formamides and lithium diisopropylamide. The process of the invention provides the N-sulfinyl α-amino amides in high yie...
|
|
WO/2014/070215A1 |
Provided herein are novel chiral sulfinamide and imine compounds. Also provided herein are methods of synthesizing novel chiral sulfinamide and imine compounds comprising simplified purification methods when compared to prior methods. Th...
|
|
WO/2013/124230A1 |
The invention relates to sulfinimidoyl- and sulfonimidoylbenzoyl derivatives of the general formula (I). In said formula (I), R, R', X, W and Z represent radicals such as hydrogen, organic radicals such as alkyl, and other radicals such ...
|
|
WO/2013/100158A1 |
An actinic ray-sensitive or radiation-sensitive resin composition, which is excellent in sensitivity, resolution, a pattern profile and a depth of focus (DOF), and, an actinic ray-sensitive or radiation-sensitive film and a pattern formi...
|
|
WO/2012/166578A2 |
Described herein are allyl ether-terminated fluoroalkylsulfinic acids and salts thereof and methods of making.
|
|
WO/2012/097550A1 |
Cyclohydrocarbyl formamide derivatives of general formula (I), preparation methods and uses thereof are provided. The present cyclohydrocarbyl formamide derivatives of general formula (I) target on the auxiliary protein Vif (Virus infect...
|
|
WO/2012/090959A1 |
The purpose of the present invention is to meet the increasing demands on fine patterns in the microfabrication field, including the manufacture of integrated-circuit elements, by providing: a radiation-sensitive resin composition that n...
|
|
WO/2012/082695A2 |
There is provided processes for preparing a perfluorovinylether sulfinate.
|
|
WO/2012/082703A2 |
There is provided a method for preparing oligomers and co-oligomers of highly fluorinated sulfinic acids and salts thereof.
|
|
WO/2011/143376A1 |
An odor control composition includes (a) at least one fragrance and (b) a halo active aromatic sulfonamide compound of Formula (I): wherein R1, R2, R3, R4, and R5 are independently selected from hydrogen, COOR', CON(R")2, alkoxy, CN, NO2...
|
|
WO/2011/110653A1 |
Solution of conductive molecular materials and electromagnetic absorbents produced from these solutions. The invention relates to a stable solution of molecular material, characterized in that it comprises: - a first type of organic or o...
|
|
WO/2011/108622A1 |
Disclosed is a preparation method for obtaining an alkali metal perfluorosulfinate by reacting a perfluoroalkane sulfinyl halide with a sulfur-containing reducing agent in the presence of water, wherein mineral salts, which are an impuri...
|
|
WO/2011/098417A1 |
Substituted cyanobutyrates of the formula I in which the variables are defined according to the description, processes and intermediates for preparing the compounds of the formula I and their N-oxides, their agriculturally suitable salts...
|
|
WO/2011/080752A1 |
A process for the preparation of perfluoroalkyl sulfenyl chloride; said process comprising i) reacting a compound of formula (I) wherein R represents an aromatic group with or without a substituent; and R' represents a halogen, with at l...
|
|
WO/2011/060113A1 |
The invention relates generally to optical agents for biomedical applications, including phototherapy. Provided are sulfenamide compounds having an acyclic S-N bond with at least one aromatic and/or heterocyclic aromatic group providing ...
|
|
WO/2011/012248A2 |
The invention relates to 2-(3-aminobenzoyl)-3-cyclopropyl-3-oxopropane nitriles of general formula (I) as herbicides. In said formula (I), X and Y are organic groups such as alkyl and other groups such as halogen, nitro and cyano.
|
|
WO/2010/132982A1 |
It is reported herein that certain muscle diseases and conditions, including forms of muscular dystrophy, are characterized by impaired insulin-dependent signaling in the muscle tissue, in essence, a form of insulin resistance. The prese...
|
